Non-core markets in N Africa represent new lure for medtechs
This article was originally published in Clinica
Executive Summary
The maturing of the established markets with their high-regulatory demands, often lengthy reimbursement procedures and ever-present pressures for central healthcare budgets to be capped or cut have caused export-minded medtechs to look further afield. Not just to the larger emerging economies, but also to the less fashionable regions that ostensibly might appear high-risk propositions.